Elizabeth Prater
Dermatology · Oklahoma City, OKNPI 1699971911
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.4% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $777 and has fallen 88.5% since, to $89 in 2025. That places this record below the midpoint for dermatology clinicians in OK, where the typical reported total is $4,319.
Across 74 payments — averaging $23.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$312
- Novartis$204
- Mayne Pharma Commercial LLC$163
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$155
- UCB, Inc.$125
- Dermira, Inc.$122
- plus $659 from 15 others
What the payments were for
- Food & beverage$1,65995%
- Education$805%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 19 | $312 |
| Novartis | 13 | $204 |
| Mayne Pharma Commercial LLC | 5 | $163 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $155 |
| UCB, Inc. | 4 | $125 |
| Dermira, Inc. | 1 | $122 |
| Pfizer | 1 | $91 |
| Regeneron Healthcare Solutions, Inc. | 5 | $80 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| AbbVie(2 entities) | 5 | $80 |
| Sun Pharmaceutical Industries Inc. | 3 | $58 |
| Amgen | 3 | $55 |
| Johnson & Johnson | 2 | $47 |
| Bristol Myers Squibb | 2 | $39 |
| Sanofi | 2 | $26 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| Aclaris Therapeutics, Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| VYNE Pharmaceuticals Inc. | 1 | $18 |
| Galderma Laboratories, L.p. | 1 | $14 |
| LEO Pharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,739 in reported general payments places this provider in the 35th percentile of 114 dermatology providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 20 | $133,435 |
| Taltz AutoinjectorIxekizumab | 12 | $85,640 |
| Dupixent PenDupilumab | 24 | $85,146 |
| Clobetasol Propionate | 14 | $756 |
| Minoxidil | 26 | $425 |
| Doxycycline Monohydrate | 13 | $315 |
| Quetiapine Fumarate | 12 | $252 |
| Amitriptyline Hcl | 16 | $186 |
| Triamcinolone Acetonide | 21 | $143 |
| Fluconazole | 14 | $115 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Oklahoma City
- Yaohan LamOklahoma City$88K
- Kimberly JerdanOklahoma City$59K
- Mark DawkinsOklahoma City$56K
- Quy PhamOklahoma City$14K
- Sunita CrittendenOklahoma City$13K
- Tiffany BrazealOklahoma City$13K
- Robert LehrOklahoma City$11K
- Courtney CookOklahoma City$10K
- Clifford HendersonOklahoma City$9K
- Roy RindlerOklahoma City$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.